Travere Therapeutics, Inc. (TVTX) ownership: insiders 2% · institutions 107% · index and ETF funds 5% (13F 2026-03-31). Insider activity, 90 days: Routine (7 sales, 0 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Janus Henderson | 11419586.00 | $339.25M | 12.3% | 2026-03-31 |
| FMR (Fidelity) | 10967967.00 | $325.86M | 11.8% | 2026-03-31 |
| BlackRock | 7792033.00 | $231.50M | 8.4% | 2026-03-31 |
| Vanguard | 6480719.00 | $192.54M | 7.0% | 2026-03-31 |
| State Street | 4959988.00 | $147.36M | 5.3% | 2026-03-31 |
| Armistice Capital, LLC | 4897417.00 | $145.50M | 5.3% | 2026-03-31 |
| Perceptive Advisors LLC | 4142551.00 | $123.08M | 4.5% | 2026-03-31 |
| Nomura | 3270513.00 | $97.17M | 3.5% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-06-22 |
Back to TVTX overview · TVTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.